XML 33 R20.htm IDEA: XBRL DOCUMENT

Income Taxes	9 Months Ended
Sep. 30, 2020
Income Tax Disclosure [Abstract]
Income Taxes	12. INCOME TAXES Income tax benefit for the three months ended September 30, 2020 was $0.5 million as compared to income tax benefit of $0.1 million for the three months ended September 30, 2019. Income tax benefit for the nine months ended September 30, 2020 was $0.2 million as compared to income tax benefit of $0.6 million for the nine months ended September 30, 2019. The income tax benefit for the three and nine months ended September 30, 2020 and 2019, were primarily attributable to non- U.S. tax benefit associated with the Company's non-U.S. operations. The primary difference between the effective tax rate and the statutory tax rate relates to the valuation allowance on the Company’s U.S. losses. A valuation allowance is provided when it is more likely than not that some portion of the deferred tax assets will not be realized through future operations. As a result of the Company’s analysis of all available objective evidence, both positive and negative, as of September 30, 2020, management believes it is more likely than not that the deferred tax assets will not be fully realizable. Accordingly, the Company has provided a full valuation allowance against its deferred tax assets with the exception of deferred tax assets related to foreign entities in the UK, Brazil, China, India, Netherlands, and Denmark. On June 29, 2020, California enacted legislative changes that impose an annual cap of $5.0 million on the amount of business incentive tax credits the Company can utilize in California effective for tax years 2020 through 2022. The legislation has no impact to the Company’s tax provision due to our full valuation allowance.

Income Taxes

9 Months Ended

Sep. 30, 2020

12. INCOME TAXES

Income tax benefit for the three months ended September 30, 2020 was $0.5 million as compared to income tax benefit of $0.1 million for the three months ended September 30, 2019. Income tax benefit for the nine months ended September 30, 2020 was $0.2 million as compared to income tax benefit of $0.6 million for the nine months ended September 30, 2019. The income tax benefit for the three and nine months ended September 30, 2020 and 2019, were primarily attributable to non-

U.S. tax benefit associated with the Company's non-U.S. operations. The primary difference between the effective tax rate and the statutory tax rate relates to the valuation allowance on the Company’s U.S. losses.

A valuation allowance is provided when it is more likely than not that some portion of the deferred tax assets will not be realized through future operations. As a result of the Company’s analysis of all available objective evidence, both positive and negative, as of September 30, 2020, management believes it is more likely than not that the deferred tax assets will not be fully realizable. Accordingly, the Company has provided a full valuation allowance against its deferred tax assets with the exception of deferred tax assets related to foreign entities in the UK, Brazil, China, India, Netherlands, and Denmark.

On June 29, 2020, California enacted legislative changes that impose an annual cap of $5.0 million on the amount of business incentive tax credits the Company can utilize in California effective for tax years 2020 through 2022. The legislation has no impact to the Company’s tax provision due to our full valuation allowance.

- Definition

The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.

+ References + Details